About the Innate Killer Summit

This Summit Delves into The Clinical Challenges & Advantages of NK Cell Therapies, NK-Engagers, Bispecific-Based Approaches & Combination Therapies - Such Exploration Is Pivotal for Maximizing the Potential of Innate Immune Responses

As the go-to conference for networking to achieve clinical excellence we take pride in curating an industry tailored agenda that will have something for you and every member of your project team. 

Our goal this year to reinvigorate confidence within the space through: 

  • A jam-packed preconference workshop day with 6 different workshops and a bootcamp ranging from preclinical to CMC and process development – great for you and your entire team to attend! 
  • 10+ plenary talks across the main conference days where experts will guide you through the current cell therapy landscape, an industry leaders annual briefing, a range of clinical data presentations on engineered and non-engineered NK cell therapies and engagers and an investors panel aimed to reignite investors and pharma interest in NK cells. 

Specific sessions to look forward to include:

Engineered NK-92 (aNKTM) Cells – Preclinical & Clinical Results - with Hans Klingemann, CSO, Immunity Bio 

Bringing A MAGE-A4 Targeting “Off the Shelf” TCR-NK Cells Into the Clinic: Leveraging Pre-Clinical and Manufacturing Interplay - with Emilie Gauthy, Head of CMC, Zelluna Immunotherapy

Clinical Data of AFM13 + NK Cells; An Outlook of the New Study by Affimed - with Joachim Koch, VicePresident & Head Discovery Research & Translational Immunology, Affimed

Navigating Key Challenges in Potency Assay Implementation for Cell Therapeutics – a Workshop led by Austin Bigley, Vice President - Research & Development, Indapta Therapeutics

Bispecific Antibodies & AI ML; Discussing the Engineering of Cytovia’s NK Engager Scaffold to treat Rare & Common Autoimmune & Inflammatory Diseases - with Armin Rath, COO & Tony Arulanandam, SVP & Head of Preclinical R&D, Cytovia 

Assessing the Ideal Conditions for NK Cell Growth and Persistence in Engineered NK Cells – a Workshop led by Juliana Vergara, Principal Scientist, Senti Biosciences 

... and many more!

Don't Take It From Us - See What Your Peers Have to Say:

"All the speakers were very eloquent, clear and easy to follow. Many of them had incredible insight"
A*STAR (Agency for Science, Technology and Research)

*****

"Everyone I interacted with was very friendly, from organizers to attendees and vendors/sponsors. The presentations and topics were very informative and I feel that I learned a lot about the industry and the science at this summit"
Astellas

*****

"Fantastic talks, excellent presentation, excellent opportunities to meet and discuss with colleagues and experts in the field"
Imperial College London

*****

"The translational impact and nature of the work that was being presented were outstanding. You get a lot of insights from your peers regarding their experience interacting with the regulatory agencies"
Onk Therapeutics

*****

"World-class speakers!"
Vycellix